how many people are on glp-1 drugs in the us Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss GLP-1 Antagonists Increase Plan Drug
Description
However, new research has found that up to one in 10 people may have genetic variants that make them resistant to the effects of these drugs
He, X., Guan, H., Liang, W., Huang, Z., Xu, L., Zhang, P., et al
Patients should understand that expected weight loss varies by medication (approximately 5-10% with liraglutide, 10-15% with semaglutide, and potentially higher with tirzepatide), though responses in post-bariatric patients may differ from those in primary obesity treatment
What Else is New with GLP-1s While much of the news about health insurance coverage for GLP-1s is bad, there's good news too
Research indicates that as much as 6070% of the weight lost may come back within just a few months
Current evidence suggests that the benefits of glycaemic control and weight reduction likely outweigh theoretical cancer concerns for most patients
